Genomic Urine Testing Market: Size, Share, and Growth Trajectory Through 2035
Overview:
The global genomic urine testing market is poised for notable expansion, with increasing applications in diagnostics and personalized medicine. The market is projected to reach USD 137.0 million in 2025, driven by technological advancements and the growing prevalence of urinary tract infections and bladder cancer.
Revenue forecasts suggest a robust growth trajectory, estimating a market size of USD 293.6 million by 2035. This expansion corresponds to a compound annual growth rate (CAGR) of 7.9% from 2025 to 2035, reflecting increasing adoption and integration of genomic urine testing in clinical settings.
The rising demand for non-invasive diagnostic methods and the ability of genomic urine testing to provide accurate and early detection of diseases are key market drivers. The base year for estimation is 2024, with historical data spanning from 2018 to 2024, providing a comprehensive view of market trends and developments.
The forecast period from 2025 to 2035 accounts for quantitative units such as revenue in USD million and CAGR, offering a clear financial outlook for stakeholders. Report coverage includes revenue forecasts, competitive landscapes, company market shares, growth factors, and emerging trends.
Market segments covered encompass application, end-user, and regional scope, providing a detailed analysis of the market’s structure and dynamics. Regional analysis includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, each presenting unique growth opportunities.
Country-level analysis focuses on key markets such as the U.S., Canada, Mexico, U.K., Germany, Italy, Poland, China, India, Japan, Australia, South Korea, Brazil, UAE, KSA, and South Africa, offering granular insights for strategic decision-making.
Year On Year Growth Chart
“`html
| Report Attribute | Details |
|---|---|
| Market Size in 2025 | USD 137.0 million |
| Revenue Forecast for 2035 | USD 293.6 million |
| Growth Rate (CAGR) | 7.9% from 2025 to 2035 |
| Base Year for Estimation | 2024 |
| Historical Data | 2018 – 2024 |
| Forecast Period | 2025 – 2035 |
| Quantitative Units | Revenue in USD million and CAGR from 2025 to 2035 |
| Report Coverage | Revenue forecast, company market share, competitive landscape, growth factors, and trends |
| Covered Segments | Application, end-user, and region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, MEA |
| Country Scope | U.S., Canada, Mexico, U.K., Germany, Italy, Poland, China, India, Japan, Australia, South Korea, Brazil, UAE, KSA, South Africa |
| Key Companies Analyzed | QIAGEN, Becton, Dickinson and Company (BD), Eurofins Scientific, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Illumina, Inc. |
| Customization Options | Free report customization (up to 8 analysts working days) with purchase. Changes to country, regional, and segment scope |
| Pricing and Purchase Options | Customizable purchase options for tailored research needs |
“`
Key Companies Market Share
Report Coverage & Deliverables
- Market Trends And Dynamics
- Competitve Benchmarking
- Historical data and forecasts
- Value/Volume analysis
- Company revenue shares and key strategies
- Regional opportunities
This is an indicative segmentation. Please request a sample report to see detail segmentation of this market.
Detailed Market Segmentation
- By Application
- Diagnosis of Urinary Tract Infections
- Bladder Cancer Detection
- Kidney Disease Monitoring
- Genetic Screening
- By End-user
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Specialty Clinics
- By Region
- North America (U.S., Canada, Mexico)
- Europe (U.K., Germany, France, Italy, Poland)
- Asia-Pacific (China, India, Japan, Australia, South Korea)
- Latin America (Brazil, Argentina)
- Middle East & Africa (UAE, Saudi Arabia, South Africa)
Table of Content
- Executive Summary
- Market Overview
- Key Market Dynamics
- Market Trends and Developments
- Market Drivers and Restraints
- Global Market Forecast 2025-2035
- Market Analysis, by Application
- Diagnosis of Urinary Tract Infections
- Bladder Cancer Detection
- Kidney Disease Monitoring
- Genetic Screening
- Market Analysis, by End-user
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Specialty Clinics
- Regional Market Analysis
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- North America Market Forecast 2025-2035
- Europe Market Forecast 2025-2035
- Asia Pacific Market Forecast 2025-2035
- Latin America Market Forecast 2025-2035
- Middle East & Africa Market Forecast 2025-2035
- Competitive Landscape
- Key Company Profiles
- Market Strategies and Developments
- Regulatory Framework
- Research Methodology
- Assumptions and Acronyms